Alemtuzumab Induction Therapy in Elderly Kidney Transplant Recipients.

被引：0
|
作者：
Yakubu, I. [1 ]
Masters, B. [1 ]
Ravichandran, B. [1 ]
Sparkes, T. [1 ]
Moss, M. [1 ]
Rasetto, F. [1 ]
Jonchhe, S. [1 ]
Thomas, B. [2 ]
Costa, N. [2 ]
Leeser, D. [2 ]
Bartlett, S. [2 ]
Haririan, A. [2 ]
机构：
[1] Univ Maryland, Med Ctr, Pharm, Baltimore, MD 21201 USA
[2] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C38
引用
收藏
页码：613 / 614
页数：2
相关论文
共 50 条
  • [21] A Pharmacoeconomic Analysis of Alemtuzumab Versus Thymoglobulin Induction in Renal Transplant Recipients.
    Tseng, Christine Y.
    Truscott, Christie B.
    Zavala, Edward
    Feurer, Irene
    Shaffer, David
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 370 - 370
  • [22] BK Virus Infection With Alemtuzumab Induction in Pediatric Kidney Transplant Recipients. A Single Center Experience.
    Al-Uzri, A.
    Patel, T.
    Nolt, D.
    Jenkins, R.
    Iragorri, S.
    Rozansky, D.
    Munar, M.
    TRANSPLANTATION, 2014, 98 : 502 - 502
  • [23] Outcomes Using Alemtuzumab Induction in Pediatric Kidney Transplant Recipients
    Zhang Yifeng
    Kumar, Juhi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [24] Alemtuzumab Induction in Sensitized, Kidney Re-Transplant Recipients
    Shaffer, I.
    Hale, D.
    Moore, D.
    Schaefer, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 251 - 251
  • [25] INDUCTION THERAPY IN ELDERLY KIDNEY TRANSPLANT RECIPIENTS WITH LOW IMMUNOLOGICAL RISK
    Masset, C.
    Boucquemont, J.
    Garandeau, C.
    Buron, F.
    Morelon, E.
    Girerd, S.
    Ladriere, M.
    Mourad, G.
    Garrigue, V.
    Cassuto, E.
    Albano, L.
    Foucher, Y.
    Dantal, J.
    TRANSPLANT INTERNATIONAL, 2020, 33 : 11 - 11
  • [26] Induction Therapy in Elderly Kidney Transplant Recipients: Is Thymoglobulin Too Much?
    Dube, Geoffrey K.
    Crew, Russell J.
    Cohen, David J.
    Ratner, Lloyd E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 323 - 323
  • [27] Induction Therapy in Elderly Kidney Transplant Recipients With Low Immunological Risk
    Masset, Christophe
    Boucquemont, Julie
    Garandeau, Claire
    Buron, Fanny
    Morelon, Emmanuel
    Girerd, Sophie
    Ladriere, Marc
    Mourad, Georges
    Garrigue, Valerie
    Cassuto, Elisabeth
    Albano, Laetitia
    Foucher, Yohann
    Dental, Jacques
    TRANSPLANTATION, 2020, 104 (03) : 613 - 622
  • [28] Alemtuzumab Induction in Non-Hepatitis C Positive Liver Transplant Recipients.
    Levitsky, Josh
    Thudi, Kavitha
    Ison, Michael G.
    Abecassis, Michael
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 328 - 328
  • [29] The Impact of Induction Therapy on Clinical Outcomes and Quality of Life in Aged Kidney Transplant Recipients.
    Taber, D.
    Bratton, C.
    Al Manasra, A.
    Pilch, N.
    Meadows, H.
    McGillicuddy, J.
    Chavin, K.
    Baliga, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 429 - 429
  • [30] Decreased Long-Term Survival with Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients.
    Bajjoka, I.
    Yaldo, A.
    Crombez, C.
    Abouljoud, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 329 - 329
12345